ALB and type 2 diabetes mellitus: The FIDELIO-DKD study [115] included 5674 patients with T2DM, a urinary albumin/creatinine ratio of 30–5000 mg/g and eGFR of ≥25 to <75 mL/min/1.73 m2, treated with maximum tolerated doses of renin-angiotensin system inhibitors.